The largest database of trusted experimental protocols

13 protocols using transforming growth factor β

1

Treg Cell Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were stimulated with anti-CD3 (2 μg/mL) (eBioscience), anti-CD28 (1 μg/mL) (eBioscience), IL-2 (50 ng/mL) (R&D Systems), and transforming growth factor β (20 ng/mL) (R&D Systems) and cultured for 3 days for Treg cell induction.
+ Open protocol
+ Expand
2

Th17 Differentiation from CD4+CD25- T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD25 T cells were isolated from spleens of 6-month-old mice as described previously (25 (link)). Cells were purified using a MACS magnetic column (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) with a CD4+ T cell enrichment kit (11-0041-82; eBioscience; Thermo Fisher Scientific, Inc.). The cells were then stimulated with a plate-bound anti-CD3e antibody (5 µg/ml; 11-0038-42, eBioscience; Thermo Fisher Scientific, Inc.) and anti-CD28 antibody (2 µg/ml; 16-0281-82, eBioscience; Thermo Fisher Scientific, Inc.). For Th17-cell polarization, the following exogenous cytokines and antibodies were added: Transforming growth factor-β (5 ng/ml, R&D Systems); anti-IL-4 antibody (46-7041-82; 10 µg/ml; eBioscience; Thermo Fisher Scientific, Inc.); IL-6 (MAB406; 30 ng/ml; R&D Systems); anti-IFN-γ antibody (MAB485; 10 µg/ml; eBioscience; Thermo Fisher Scientific, Inc.) and IL-1β (AF-401-NA; 20 ng/ml; R&D Systems). After 5 days of culture, the proportion of Th17 cells among all cells was determined by flow cytometry.
+ Open protocol
+ Expand
3

Plasma Protein Markers in RFCA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples were taken before RFCA and the plasma levels of the following protein markers were measured using enzyme-linked immunosorbent assay kits: tissue inhibitor of metalloproteinases-1 (TIMP-1; R&D Systems, Minneapolis, MN, USA), transforming growth factor-β (R&D Systems, Minneapolis, MN, USA), and pro-atrial natriuretic peptide (pro-ANP; Biomedica, Antony, France).
+ Open protocol
+ Expand
4

Generating Langerin-expressing Epstein–Barr Virus-transformed BLCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Langerin expressing Epstein–Barr virus-transformed BLCs were used as autologous APC (van der Vlist et al., 2011 (link)) and were cultured in RPMI 1640 (InvitrogenTM) supplemented with 10% fetal calf serum (Biowittaker), 1% penicillin, and streptomycin (both Lonza). Langerin-expressing MUTZ-3-derived LCs were differentiated from the MUTZ-3 progenitor cell line with 100 ng/mL granulocyte-macrophage colony-stimulating factor (Biosource), 10 ng/mL transforming growth factor β (R&D Systems), and 2.5 ng/mL tumor necrosis factor α (Miltenyi) (de Jong et al., 2010 (link)).
+ Open protocol
+ Expand
5

Osteoclast Differentiation from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs isolated by density gradient centrifugation were plated in 96-well culture plates as described before.19 (link) PBMCs were left overnight for osteoclast precursors (OCPs) to adhere on bone slices (Immunodiagnostic Systems, Boldon, UK).20 (link) On the following day (day 1 of culture), medium was changed to Dulbecco's modified Eagle's Medium (DMEM) supplemented with macrophage colony stimulating factors (M-CSF) 25 ng/mL (Peprotech, London, UK). Three days later, medium was again changed to DMEM with M-CSF (25 ng/mL), soluble RANKL (sRANKL) (50 ng/mL; Peprotech), dexamethasone (10 nM; Sigma-Aldrich) and transforming growth factor β (2.5 ng/mL; R&D Systems) in order to differentiate the OCPs into mature OC.21 (link) The culture medium was then changed twice a week. Cells cultured on bone slices for 7, 14 and 21 days20 22 (link) were used for functional assays and gene expression.
+ Open protocol
+ Expand
6

Differentiation of hESCs and hiPSCs into Germ Layers

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9 hESCs (WiCell, Madison, WI, USA) and the hiPSC lines FSPS13B, CF03, CF04, and CF05 were plated on vitronectin-coated plates (10 μg/mL, Stem Cell Technologies) and cultured in E6 media supplemented with 2 ng/mL transforming growth factor β (R&D) and 25 ng/mL fibroblast growth factor 2 (Dr. Marko Hyvönen, Cambridge University) making complete E8 media. Cells were maintained by weekly passaging using 0.5 mM EDTA (Thermo Fisher Scientific). The cells were differentiated into the three germ layers and functional cell types as previously described (Cheung et al., 2012 (link), Mendjan et al., 2014 (link)) and as described in the Supplemental Information.
+ Open protocol
+ Expand
7

Induction of Human Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs were obtained from blood samples of healthy donors (Shanghai Blood Center) with ethical approval from Shanghai Blood Center Ethics Committee. Human CD4+CD25lowCD127highCD45RA+ naïve CD4+ T cells were sorted by BD FACS Aria II cell sorter and differentiated into inducible Treg cells in X-VIVO (Lonza, Malkersville, USA, Cat#04-418Q) medium supplemented with 10% fetal bovine serum (Invitrogen, Maltham, USA, Cat#10100147), 1% GlutaMAX, 1% sodium pyruvate, 1% minimum essential medium with nonessential amino acids, 1% penicillin-streptomycin, 100 U/mL IL2 (R&D systems, Minneapolis, USA, Cat#202-IL), and 5 ng/mL transforming growth factor-β (R&D Systems, Cat#240-B), in the presence of Dynabeads Human T-activator CD3/CD28 (Gibco, Cat#11 132D) at a bead-to-cell ratio of 1:4. Approximately 7 days later, the differentiation efficiency reached at least 90% and could be used for analysis.
+ Open protocol
+ Expand
8

Isolation and Th17 Differentiation of Murine CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were isolated from the spleen of wild-type Balb/c mice via magnetic-activated cell sorting using a CD4+ T Cell Isolation Kit (Miltenyi Biotec, Germany), in accordance with the manufacturer’s instructions. The RPMI medium for stimulating Th17 cell differentiation included 10 μg/ml anti-CD3 (eBioscience, USA), 1.5 μg/ml anti-CD28 (eBioscience), 5 ng/ml transforming growth factor-β (R&D Systems, USA), and 20 ng/ml IL-6 (BioLegend, USA). After cells had been cultured in this conditioned medium for 2 days at 37°C, 100 μl of the supernatant was analyzed for mouse IL-17 (mIL-17) using an IL-17-specific enzyme-linked immunosorbent assay (ELISA). All tests were repeated three times independently, and the means and standard deviations (SDs) from three tests were calculated.
+ Open protocol
+ Expand
9

Isolation and Stimulation of Cardiac Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts were isolated from normal WT and IRAK-M null mouse hearts as previously described and cultured in Corning T150mm × 25mm dishes [26 (link)],[27 (link)],[28 (link)]. Cells were serum-starved at passage 2 for 24h and subsequently stimulated with 10 ng/ml of Transforming Growth Factor (TGF)-β (R&D Systems, Minneapolis MN) for 1h, 4h and 24h. At the end of stimulation total protein was extracted using RIPA lysis buffer (Pierce). Protein samples were used for assessment of Smad2 phosphorylation. In additional experiments, cardiac fibroblasts from WT and IRAK-M null mice were stimulated in the presence and absence of TGF-β (10 ng/ml) for 72h and protein was harvested to assess expression of α-SMA and type III collagen.
+ Open protocol
+ Expand
10

Th17 Cell Differentiation from Naive CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were isolated from the spleen of WT Balb/c mice using magnetic activated cell sorting (MACS) CD4+ T Cell Isolation kit (Miltenyi Biotec, Cologne, Germany) according to the manufacturer’s instructions. The RPMI medium for stimulating Th17 cell differentiation included 1 μg/mL anti-CD3 (eBioscience, San Diego, CA, USA), 1 μg/mL anti-CD28 (eBioscience), 2 ng/mL transforming growth factor (TGF)-β (R&D systems, Minneapolis, MN, USA), 20 ng/mL IL-6 (BioLegend, San Diego, CA, USA), 5 μg/mL anti-IFN-γ (BioLegend) and 5 μg/mL anti-IL-4 (BioLegend). Cells were cultured in this conditioned medium for 3 days. At day 0, tIK protein or phosphate-buffered saline (PBS) as a control was added.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!